TABLE 3

Time-Dependent Uptake of 99mTc(I)-Estradiol-Pyridin-2-yl Hydrazine Derivative

%ID/g at the following time (h) after injection:
Organ1324
Kidneys1.70 ± 0.331.31 ± 0.061.19 ± 0.12
Adrenal glands1.87 ± 0.753.10 ± 0.460.58 ± 0.15
Heart1.17 ± 0.231.61 ± 0.510.86 ± 0.12
Small intestine0.44 ± 0.201.87 ± 0.540.68 ± 0.05
Large intestine0.28 ± 0.063.24 ± 0.950.89 ± 0.19
Liver9.48 ± 0.998.34 ± 0.187.84 ± 0.24
Urinary bladder0.19 ± 0.050.96 ± 0.275.99 ± 4.34
Blood2.47 ± 0.072.79 ± 0.211.02 ± 0.39
Bone0.28 ± 0.160.14 ± 0.010.85 ± 0.53
Lungs1.49 ± 0.391.12 ± 0.190.83 ± 0.17
Stomach0.85 ± 0.141.08 ± 0.370.34 ± 0.04
Muscle0.10 ± 0.010.18 ± 0.030.35 ± 0.10
Mammary glands1.21 ± 0.263.07 ± 0.401.59 ± 0.59
Uterus1.32 ± 0.371.48 ± 0.101.60 ± 0.17
Ovaries1.40 ± 0.321.19 ± 0.260.97 ± 0.25
Brain0.06 ± 0.010.10 ± 0.010.02 ± 0.01
  • Uptake was determined from biodistribution studies of 99mTc(I)-estradiol-pyridin-2-yl hydrazine derivative in selected organs of 8- to 10-wk-old female C57BL/6 mice in diestrus. Data represent mean ± SEM from at least 6 determinations.